We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Next-Generation Scintillation Crystals Developed for Imaging Applications

By MedImaging International staff writers
Posted on 18 May 2009
Print article
Innovative scintillation crystal and solid-state photo detector technologies are being developed to help design advanced oncology, neurology, and cardiology imaging equipment.

Zecotek Photonics, Inc. (Vancouver, BC, Canada) has developed a system that removes a significant obstacle in the development of technologies promising to serve as a backbone for next-generation imaging equipment.

"Zecotek is favorably positioned as a global competitor, having been issued or allowed patents for its lutetium fine silicate [LFS] scintillation crystals in many countries and a series of pending and granted patents for its novel solid-state photomultiplier and depth of interaction design considerations,” said Frost & Sullivan (Palo Alto, CA, USA) industry analyst Travis Chong. "The company is integrating all these components into what it has dubbed the ‘Plug to Socket,' a very compact detector module element that captures high resolution images, is easy to install, and requires very low servicing.”

Zecotek develops advanced photodetector and solid-state technologies for PET/CT and other medical applications. The company first developed the micro-pixel avalanche photo diode (MAPD)-1 concept, whose design and performance characteristics served as a solid-state photodetector design template for the industry over the last several years. The MAPD-1 eventually evolved into the MAPD-2 and MAPD-3, providing better electrical efficiency and imaging capabilities than traditional integrated photo multiplier tubes (PMTs) in scanners.

"Specifically, the MAPD design has been demonstrated to withstand strong magnetic environments created by superconducting magnets used in magnetic resonance imaging [MRI] machines--a critical milestone in the pursuit to bring forth PET/MRI from concept to reality,” noted Mr. Chong. "This enabling technology is expected to rapidly accelerate the development and commercialization of PET/MRI, which is currently being carried out through a collaborative partnership between Zecotek and the University of Washington [Seattle, USA].”

The 64-chip MAPD-3 array, combined with Zecotek's LFS scintillation crystals, meets and/or exceeds the performance characteristics of current high-resolution PET/CT scanners. It provides finer electrical efficiency and timing resolution, allowing researchers to improve time-of-flight capabilities of a PET/CT scanner.

Based on its recent analysis of the U.S. positron emission tomography (PET) and PET/computed tomography (CT) market, Frost & Sullivan, an international growth consultancy company, recognized Zecotek Photonics with the 2009 North American Frost & Sullivan Award for Enabling Technology.

Zecotek Photonics is a photonics technology company developing leading-edge products: crystals, photo detectors, lasers, imaging, and three-dimensional (3D) display technologies, for medical, biotech, industrial, nanotech, and atomic/molecular science applications.

Related Links:

Frost & Sullivan
Zecotek Photonics

New
Needle Guide Disposable Kit
Verza
New
Mobile X-Ray Machine
MARS 15 / 30
New
Medical Radiographic X-Ray Machine
TR30N HF
Computed Tomography System
Aquilion ONE / INSIGHT Edition

Print article

Channels

Radiography

view channel
Image: AI can identify “mammographically-visible” types of interval cancers earlier by flagging them at the time of screening (Photo courtesy of ScreenPoint Medical)

AI Improves Early Detection of Interval Breast Cancers

Interval breast cancers, which occur between routine screenings, are easier to treat when detected earlier. Early detection can reduce the need for aggressive treatments and improve the chances of better outcomes.... Read more

Nuclear Medicine

view channel
Image: In vivo imaging of U-87 MG xenograft model with varying mass doses of 89Zr-labeled KLG-3 or isotype control (Photo courtesy of L Gajecki et al.; doi.org/10.2967/jnumed.124.268762)

Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors

Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.